Skip to content
value.today

Synergy Pharmaceuticals, Inc.

🇺🇸 New York, New York, USABiotechnologyFounded 2005
Total raised
$17 M
2 rounds on record
Latest round
$1 M
Jun 2011
First round on record
Feb 2009
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Synergy Pharmaceuticals, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2011$1 MNo. 2Under $2 million

Synergy Pharmaceuticals, Inc.: Raise no. 2, Jun 2011

Investors in this round

9 investors had bought by the notice of Jun 20, 2011: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $2 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
$137,287
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Florida

People named in the notice

  • Bernard K Denoyer · Executive Officer
  • Gary S Jacob · Executive Officer, Director
  • Kunwar M Shailubhai · Executive Officer
  • Alan H Joslyn · Director
  • Chris H McGuigan · Director
  • Gabriel M Cerrone · Director
  • John M Brancaccio · Director
  • Melvin K Spigelman · Director
  • Thomas H Adams · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Enclave Capital (CRD 22732) · New York, New YorkSold in CA, and outside the US

Signed by Gary S. Jacob, Ceo. Newest notice filed Jun 20, 2011. Read the notice at the SEC.

equity, optionsSEC
Feb 2009$16 MNo. 1$10 to $50 million

Synergy Pharmaceuticals, Inc.: Raise no. 1, Feb 2009

Investors in this round

45 investors had bought by the notice of Nov 18, 2009: 45 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$16 M of $18 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
$235,000
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Florida

People named in the notice

  • Bernard K. Denoyer · Executive Officer
  • Gary S. Jacob · Executive Officer, Director
  • Kunwar M. Shailubhai · Executive Officer
  • Gabriele M. Cerrone · Director
  • John K. Brancaccio · Director
  • Melvin K. Spigelman · Director
  • Thomas H. Adams · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Gary S. Jacob, Chief Executive Officer. Newest notice filed Nov 18, 2009 (1 amendment). Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Synergy Pharmaceuticals, Inc. had no revenue when it filed its newest notice of a funding round (Jun 2011).

    SEC Form D (revenue range) · Jun 2011

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jun 2011

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Synergy Pharmaceuticals, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Synergy Pharmaceuticals, Inc.
NameRoleNamed in
Bernard K DenoyerExecutive officerJun 2011
Gary S JacobExecutive officerJun 2011
Kunwar M ShailubhaiExecutive officerJun 2011
Bernard K. DenoyerExecutive officerNov 2009
Gary S. JacobExecutive officerNov 2009
Kunwar M. ShailubhaiExecutive officerNov 2009
Bernard DenoyerExecutive officerJul 2009
Kunwar ShailubhaiExecutive officerJul 2009
Alan H JoslynDirectorJun 2011
Chris H McGuiganDirectorJun 2011
Gabriel M CerroneDirectorJun 2011
Gary S JacobDirectorJun 2011
John M BrancaccioDirectorJun 2011
Melvin K SpigelmanDirectorJun 2011
Thomas H AdamsDirectorJun 2011
Gabriele M. CerroneDirectorNov 2009
Gary S. JacobDirectorNov 2009
John K. BrancaccioDirectorNov 2009
Melvin K. SpigelmanDirectorNov 2009
Thomas H. AdamsDirectorNov 2009
John BrancaccioDirectorJul 2009